Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study
Author:
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference34 articles.
1. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014
2. Influence of sacubitril/valsartan (LCZ696) on 30-day readmission after heart failure hospitalization;Desai;J Am Coll Cardiol,2016
3. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure;Creager;J Am Coll Cardiol,1985
4. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state;Cleland;Br Heart J,1985
5. Enalapril in chronic heart failure, a double-blind placebo-controlled study;Remes;Ann Clin Res,1986
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Is Sacubitril/Valsartan a Superior Agent in Heart Failure With Reduced Ejection Fraction? A Review of Randomized Comparative Trials;Hospital Pharmacy;2023-12-06
2. Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Cureus;2023-11-11
3. Comparison of Outcomes Between Sacubitril/Valsartan and Enalapril in Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2023-11-10
4. Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration;European Journal of Clinical Pharmacology;2023-06-27
5. Effects of Sacubitril–Valsartan in Patients With Various Types of Heart Failure: A Meta-analysis;Journal of Cardiovascular Pharmacology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3